Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

China · Delayed Price · Currency is CNY

49.30

+2.21 (4.69%)

Sep 30, 2026, 4:00 PM EDT

Market Cap	5.35B -17.9%
Revenue (ttm)	650.08M +6.7%
Net Income	-91.90M
EPS	-0.67
Shares Out	108.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,011,011
Open	47.78
Previous Close	47.09
Day's Range	47.00 - 50.99
52-Week Range	35.20 - 77.17
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:301096

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registratio... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 2011

Employees 1,412

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301096

Full Company Profile

Financial Performance

In 2025, SHE:301096's revenue was 677.99 million, a decrease of -15.45% compared to the previous year's 801.92 million. Losses were -90.40 million, 71.4% more than in 2024.

Financial Statements